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FLUOROACETATE AS A POSSIBLE MARKER FOR GLIAL METABOLISM IN VIVO.

Donald D. Clarke, Ph.D. and Soll Berl, M.D.*
Dept. of Chemistry, Fordham Univ. and Dept.
of Neurology, Mt. Sinai School of Medicine*
Bronx, N.Y. 10~58 and New York, N.Y. 10029*
Glucose is the major source of energy in all
brain cells and its metabolism is closely coupled to
functional activity. Advantage has been taken of this
by Sokoloff (1977) and Sokoloff et al. (1977) to study
energy metabolism in different brain areas and their
response to a variety of drugs and stimuli. For this
purpose these workers have developed the procedure for
mrasuring autoradiographically the accumulation of
[ C]-deoxyglucose into its phosphate derivative, a
compound which does not differentiate glial from neuronal metabolism. They could be enhanced if one could
differentiate glial from neuronal metabolic response
to the various experimental conditions. Conceivably,
one could then study the effect of glial metabolism
on neuronal metabolism and vice versa.
Studies on the metabolism of glutamate, glutamine, GABA and aspartate utilizing a variety of precursors (including acetate, glucose and others) indicate that these amino acids exist in brain in distinct
metabolic pools which are accessible to specific precursors (Berland Clarke, 1969). These metabolic
pools have been suggested to be associated with cellular structures, e.g. neuronal cell bodies, nerve
endings and glia (Berl et al., 1975). Considerable
circumstantial evidence from several laboratories,
utilizing radiolabeled acetate, suggest that acetate
may be selectively matabolized in the tricarboxylic
acid cycle in glial cells (Berl et al. 1975) and thus
be a marker for such cells. Several studies have
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suggested that fluoroacetate m1m1cs acetate and is
converted to fluorocitrate (Peters, et al., 1960;
Peters, et al, 1972). Unlike the citrate formed from
acetate,any fluorocitrate formed from fluoroacetate is
unlikely to be metabolized and therefore would accumulate in the mitochondria of the cells. If subtoxic
tracer doses of highly radiolabeled fluoroacetate were
administered to an animal, it should lead to the accumulation of the label in the glia and thus be a marker
for glial metabolism. If the labeling were measured
autoradiographically, it would lead to a system similar
to that developed by Sokoloff and collaborators using
[14c]-deoxyglucose but only labeling glial cells.
This would lead to a finer resolution of the events
occurring in discrete brain areas.
Some of the experimental evidence in support of
the idea that fluoroacetate affects the small pool of
glutamate active in glutamine synthesis in brain were
achieved in studies with guinea pig brain slices
(Clarke et.al., 1970). As can be seen in Table 1, lmM
fluoroacetate decreased the specific activity
(SA)
of glutamine relative to that of glutamate (RSA)
approximately fifteen fold. Fluorocitrate was approximately one-hundred times more effective than fluoroacetate in lowering the RSA of glutamine. This is
consistent with the hypothesis of nlethal synthesisn
of fluorocitrate proposed by Peters et al. (1960).
Further confirmation of the effect of fluoroacetate
on the metabolism of the small pool of glutamate is
presented in Table 2. Fluoroacetate lowered the RSA
of glutamine when labeled glutamate, aspartate or GABA
served as the labeled precursor. All of these, when
exogenously applied to brain tissue in vivo and in
vitro,have been shown to be preferentially metabolized
in the small pool believed to be associated with glia.
14
The half life of [ c] which is 5,700 yrs, precludes obtaining [14c]-fluoroacetate of sufficiently
high specific activity to allow for administration of
a subtoxic tracer dose of fluoroacetate and still permit resolution of cellular structures. Because of the
much shorter half life of tritium, viz. 12 yrs., tritium
labeled fluoroacetate can theoretically be obtained
with approximately 450 times greater specific activity
than that of the [14c] labeled compound (Table 3.).
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This should make it possible to achieve adequate radioactivity in brain tissue using tracer doses of fluoroacetate labeled with this isotope.
TABLE 1.
Effect of Fluoroacetate and Fluorocitrate on the
Labeling of Glutamate and Glutamine from [l-14c]Acetate in Guinea Pig Brain Slices •
•

Inhibitor
FluoroFluoroacetate
citrate
0
lmM
0.1 mM

0

lmM
0.1 mM
0.01 mM

SA
Glutamate

RSA
Glutamine

4
4.69 X 10
4
1.36 X 10
1.45 X 10

4

5.87
o. 40
6.13
0.04
0.08
0.56

The slices were incubated in Krebs-Ringer phosphate
buffer containing 55mM glucose and 2 ~Ci of [1-14-c]acetate (58 ~Ci./~mole). Incubation time was 10 min.
at 37°C.
SA:
Specific Activity, c.p.m./~mole.; RSA: SA Glutamine/SA Glutamate.
TABLE 2.

•

Effect of Fluoroacetate on the Labeling of Glutamate
and Glutamine from Labeled Glutamate, Aspartate and
GABA in Guinea Pig Brain Slices.
SA
RSA
Precursor
Fluoroacetate
Glutamate Glutamine
14
0
1.32
2.01
L-[U- C]-Glutamate
2.08
0.70
1 mM
14
3.45
0
2.90
L-[U- C)-Aspartate
0.38
2.66
1 mM
14
0
2.04
4.45
'Y-Amino-[l- c]0.60
2.14
Butyrate
1 mM
Incubation conditions as in Table 1. Slices were incubated with 0.5 pCi o f L-[u-14-c]-glutamate or aspartate (> 200 mCi./mmole) or l mCi. of GABA (2.7 mCi./
mmole).
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TABLE 3
- 5,730 yrs.
Half Life of ~ c
Half Life of H
- 12.3 yrs.
Ratio of Half Lives
- 466
Allowing for different
effi~iencie3 in counting ~
of l~c and H, the ratio
200.
4

•

Tritiated fluoroacetate is not available commercially. Several attempts were made by Amersham-Searle
and New England Nuclear Corp. to prepare tritia~ed
fluoroacetate of high specific activity and sufficient
purity for us. Ne~ England Nuclear Corp. sucpee9ed_in
preparing for us [ H]-fluoroacetate at a SA of 16 Ci./
mmole ~ure [3H] has a SA of 29 Ci./mgm. atom). This
was done by exchanging the hydrogen atoms of fluoromalonic acid with tritiated water followed by heating
to decarboxylate the fluoromalonate to form fluoroacetate. Before use, the tritiated fluoroacetate
supplied to us was purified by liquid chromatography
on AG-1 chloride form, (200-400 mesh). The labeled
compound was eluted from the column with O.lN HCl;
the main fraction containing 85% of the radioactivity
was neutralized with l.ON NaOH, lyophilized and taken
up in physiological saline.
Rats were prepared with indwelling catheters in
the femoral vein. The following day three rats were
each injected with 0.3 ml of [ 3H]-fluoroacetate solution (~1 mCi.) followed by 0.5 ml of normal saline.
At 10, 20 and 30 mins. the rats were decapitated,
blood collected from the severed neck, and heart,
liver and kidney dissected and frozen in isopentane
cooled in liquid N (10 & 30 mins.). These were
2
packed in dry ice and
shipped to Dr. Sokoloff for autoradiographic studies. Although the autoradiographs
were qualitatively different from those observed with
[14c]-deoxyglucose we do not have any quantitative
comparisons at this time. The brain from the 20 min.
animal was dissected into brain stem, cerebellum,
caudate nucleus and cortex and each frozen in liq. N2 •
The tissues were extracted with 0.4N perchloric
acid·
These extracts were neutralized with 5N KOH

..
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'
•

and the supernatants chromatographed on columns of
AG-1-acetate (Berl et al. 1968). The columns were
eluted with 0.05, 0.1 and 0.3N acetic acid followed by
O.lN HCl. Tritiated water was eluted in the O.OSN
acetic acid and aspartate with 0.3N acetic acid.
Fluoroacetate, citrate and fluorocitrate were eluted
with O.lN HCl. The elution position of acetate and
fluoroacetate were determined with the tritiated compounds and that of citrate and fluorocitrate by their
color reactions developed with acetic anhydride and
pyridine (Hartford, 1962).
The distribution of the radioactivity in the
various organs is summarized in Table ~. It is obvithat within the time period of this study very little
of the fluoroacetate was metabolized in any of the organs. In agreement with others, kidney and heart
metabolized fluoroacetate to the greatest extent (Gal,
1972). In brain, unmetabolized fluoroacetate accounted for approximately 95% of the radioactivity in the
tissue. Only trace amounts, if any, of fluorocitrate
appeared to be formed. Metabolic products do not
appear to be accumulating in the serum which makes
transfer of metabolites between organs unlikely.

,
•

These results, obtained in different areas of the
brain, raise the question of whether any significant
quantities of fluorocitrate are synthesized in brain.
Even in heart and liver the significance of the extent
of formation of fluorocitrate is open to question. The
accumulation of fluorocitrate in any organ of a fluoroacetate poisoned animal has never been adequately de~
monstrated by isolation techniques. Several chromatographic identifications have been made. The theory of
nlethal synthesis" of fluorocitrate was based on the
well demonstrated accumulation of citrate in kidney
and heart (Peters et , al., 1960). This has been repeatedly confirmed and corroborated in the brains of
rats by Goldberg, et al. (1966). Accumulation of
fluorocitrate from fluoroacetate to the extent of
about 2% (on a weight basis) of the radioactivity in
brai£~is suggested by studies using convulsive doses
of [ C]-labeled fluoroacetate (Gal, 1972). The identif ication of fluorocitrate in those studies was by
paper chromatography. In the studies reported here

N

w

-

TABLE 4.

CD

Distribution of Radioactivity after I.V. Administration of Tritiated
Fluoroacetate
Total c.p.m./~
of Tissue x 10
Cortex
Caudate Nucleus
Cerebellum
Pons-Medulla
Liver
Heart
Kidney
Serum

% of Radioactivity in the Tissue
3
2.3
2.2
2.2
2.0
2.6
4.0
2.2
5.3

H0
2

3.7
3.6
3.9
3.6
3.6
8.0
10.3
0.1

FAc
94.4
96.3
94.8
94.5
92.7
86.3
82.1
97.2

Ac

Cit.

(0. 02

(0.1
(0.02
(0.1
(0. 02
(0.1
(0. 02
(0.1
.JVQ. 01
"-'1.0
,...,1.0
""'0. 4
tV 0. 4
rVl.O
(0.001 (D. 02

FCit.
(0. 02
(0.02
<D.02
~0. 02
r..;~Q.l

--0.25
NQ.35
(0.001

Asp.

Glu
tv0.05
"-'0. 0 5
N0.05
tv0.05
"-'0 .15
1'-"0 • 6

r.J0.05
r.-~0.05

0. 0 5
,vQ.05
tv0.15
.N0.3
,AJ 0. 4
~o.s
(0.001 (0.001
.f\.J

Approximately 1 mCi. of purified tritiated sodium fluoroacetate (16 Ci./mmole) was
injected via an indwelling catheter in the femoral vein. After 20 minutes the rat
was decapitated, blood collected, the tissues dissected and frozen in liquid N •
2
The tissues were extracted with 0.4N perchloric acid. The extracts were neutralized with 5N KOH and the supernatants chromatographed on columns of AG-l-X4,
200-400 mesh in the acetate form.
FAc:
Glu:

Fluoroacetate; Ac: Acetate;
Glutamate; Asp: Aspartate.

.

.

..

.,

Cit:

Citrate;

FCit: Fluorocitrate;

•
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tracer doses of labeled fluoroacetate were used.
Accordingly these studies need to be repeated using
higher doses of fluoroacetate before more definitive
statements about the extent of synthesis of fluorocitrate in brain can be made.

,

Synthetic fluorocitrate has been repeatedly shown
to inhibit aconitase and biosynthesis of fluorocitrate
from synthetic fluoroacetyl-coenzyme A by mitochondrial preparations has been adequately demonstrated.
It therefore seems that it is not the theory of lethal
synthesis which should be questioned but the competitive inhibition of aconitase as an explanation for the
accumulation of citrate. It would seem more likely
that fluorocitrate may be a suicide substrate for mitochondrial aconitase and this leads to the accumulation
of Citrate. The low rate of synthesis of fluorocitrate and its utilization as a substrate by aconitase
accompanied by the concomittant destruction of aconitase would better seem to explain the time dependence
of fluoroacetate toxicity and the failure to isolate
fluorocitrate from poisoned animals to date.
It therefore seems that one of our starting assumptions is probably not true, viz. that fluorocitrate
is a non-metabolizable compound. This however does
not invalidate our thesis because fluoroacetate seems
to fit the description of a practically non-metabolizable compound. As shown above, in tracer doses, at
least 95% of the radioactivity remains unmetabolized.
If fluoroacetate is taken up predominantly by glia and
its uptake is affected by changes in glial metabolism,
then it can still be a useful marker of glial function.
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